fda glp-1 compounding enforcement news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our fda glp-1 compounding enforcement news

Obesity has further been associated with higher disease activity and reduced time to flare

A major new clinical trial is putting a spotlight on one of the biggest conversations in medicine right now: what happens when GLP-1based therapy is brought into psoriatic arthritis care

Clean, Vegan, and Transparency-Focused: Optiwav 12-in-1 GLP-1 Support is a clean-label vegan supplement made without sugar, gluten, soy, dairy, or artificial additives

Medicare GLP-1 Bridge program offers $50 copayment for weight loss drugs to eligible Medicare beneficiaries.

Frequently asked questions

Consumer-directed health care in a retail health context is a growing force as patients face high deductibles, denials of care, lack of access, now demanding convenience and retail-style omni-channel on-ramps for care, products, support, and I daresay, respect and empathy